Cargando…
Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology
The past decade has witnessed an outstanding scientific production focused towards the possible clinical applications of mesenchymal stromal cells (MSCs) in autoimmune and chronic inflammatory diseases. This raised the need of novel standards to adequately address quality, efficacy and safety issues...
Autores principales: | Dothel, Giovanni, Raschi, Emanuel, Rimondini, Roberto, De Ponti, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107589/ https://www.ncbi.nlm.nih.gov/pubmed/27895395 http://dx.doi.org/10.3748/wjg.v22.i41.9057 |
Ejemplares similares
-
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System
por: Fusaroli, Michele, et al.
Publicado: (2022) -
Ex vivo effect of vascular wall stromal cells secretome on enteric ganglia
por: Dothel, Giovanni, et al.
Publicado: (2019) -
Drug-induced liver injury: Towards early prediction and risk stratification
por: Raschi, Emanuel, et al.
Publicado: (2017) -
Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors
por: Raschi, Emanuel, et al.
Publicado: (2019) -
Phytoestrogens in Postmenopause: The State of the Art from a Chemical, Pharmacological and Regulatory Perspective
por: Poluzzi, Elisabetta, et al.
Publicado: (2014)